Ileal interposition with sleeve gastrectomy for control of type 2 diabetes.

@article{Kumar2009IlealIW,
  title={Ileal interposition with sleeve gastrectomy for control of type 2 diabetes.},
  author={K V S Hari Kumar and Surendra Ugale and Neeraj Gupta and Vishwas Naik and Pawan Kumar and Prashanth P Bhaskar and Kirtikumar D. Modi},
  journal={Diabetes technology \& therapeutics},
  year={2009},
  volume={11 12},
  pages={
          785-9
        }
}
BACKGROUND Bariatric surgery offers the best solution in management of obesity and related metabolic ailments, paving the way for a concept termed metabolic surgery. We report the results of a novel surgical procedure on glycemic control and metabolic syndrome in poorly controlled type 2 diabetes. METHODS Ten patients (four men, six women) underwent laparoscopic surgical procedure of sleeve gastrectomy and ileal interposition. All patients had diabetes for more than 3 years with poor control… 
View on PubMed
mecev.org
44 Citations
Highly Influential Citations
3
Background Citations
13
Methods Citations
1

44 Citations

Citation Type

Citation Type

Laparoscopic ileal interposition with diverted sleeve gastrectomy for treatment of type 2 diabetes.
Ileal Interposition with Gastric Bipartition and a Weight-Adjusted Sleeve Gastrectomy: A New Model of Metabolic Surgery
TLDR
Ileal interposition with gastric bipartition and a weight-adjusted sleeve gastrectomy is a safe and effective procedure for treatment of type 2 diabetes patients with or without obesity.
Short-Term and Mid-Term Control of Type 2 Diabetes Mellitus by Laparoscopic Sleeve Gastrectomy with Ileal Interposition
TLDR
Adequate glycemic control, adjustable weight loss, and absence of nutritional deficiencies were the main benefits offered by the surgical intervention.
Impact on Dyslipidemia of the Laparoscopic Ileal Interposition Associated to Sleeve Gastrectomy in Type 2 Diabetic Patients
TLDR
The laparoscopic ileal interposition associated to sleeve gastrectomy was an effective operation for the regression of dyslipidemia and T2DM in a non-obese population.
Ileal interposition surgery for treatment of type 2 diabetes mellitus-pros and cons
TLDR
Although Ileal Interposition is an effective treatment option, this procedure is not recommended for general use and long-term studies are needed to confirm these findings and potential side effects on a larger number of patients.
Role of Laparoscopic Ileal Interposition Associated with Sleeve Gastrectomy in Management of Type 2 Diabetes Mellitus
TLDR
The results of this procedure are promising regarding its outcome in remission of T2DM and remission of its co-morbidity diseases and the procedure seems to be safe and an effective option in the management of type 2 diabetes patients with affordable risk comparing to its long term benefits.
The impact of laparoscopic diverted sleeve gastrectomy with ileal transposition (DSIT) on short term diabetic medication costs
TLDR
Diverted sleeve gastrectomy with ileal interposition led to a marked reduction in BMI and improved glycemic control after 1 year follow-up and showed that DSIT operation leads to a significantly better gly glucose control and lower diabetic medication costs at 1  year.
Early Mechanisms of Glucose Improvement following Laparoscopic Ileal Interposition Associated with a Sleeve Gastrectomy Evaluated by the Euglycemic Hyperinsulinemic Clamp in Type 2 Diabetic Patients with BMI below 35
TLDR
According to the clamp technique, II-SG significantly improved IS and β-cell function as early as 30 days postoperatively in a T2DM population with a BMI of 21.9–33.8.
Surgical Treatment of Type 2 Diabetes in Patients with BMI Below 35: Mid-term Outcomes of the Laparoscopic Ileal Interposition Associated with a Sleeve Gastrectomy in 202 Consecutive Cases
TLDR
Both JII-SG and DII- SG demonstrated to be safe, effective, and long-lasting alternatives for the treatment of type 2 diabetes mellitus patients with BMI below 35.
Alas! Ileal interposition surgery for diabetes prevention?
TLDR
In this issue of GASTROENTEROLOGY, Cummings et al have performed a comprehensive analysis of ileal interposition (IT) surgery in a rat model that closely mimics the metabolic syndrome in humans.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 14 REFERENCES
Laparoscopic treatment of type 2 diabetes mellitus for patients with a body mass index less than 35
TLDR
The laparoscopic ileal interposition via either a sleeve Gastrectomy or diverted sleeve gastrectomy seems to be a promising procedure for the control of type 2 diabetes mellitus and the metabolic syndrome.
Ilial Transposition and Enteroglucagon/GLP-1 in Obesity (and Diabetic?) Surgery
TLDR
It appears from all that is now known about GLP-1 that ileal transposition would be an ideal operation for treatment of type 2 DM, and this is a recommendation for well-planned studies of ileAL transposition in the treatment oftype 2 DM and obesity.
Duodenal-jejunal bypass for the treatment of type 2 diabetes in patients with body mass index of 22-34 kg/m2: a report of 2 cases.
Effects of obesity surgery on non-insulin-dependent diabetes mellitus.
TLDR
Although all of the surgical procedures for obesity offer improved weight loss and diabetes control compared with conservative methods, the Roux-en-Y gastric bypass and biliary-pancreatic diversion offer superior weight Loss and resolution of diabetes.
[Current status of obesity surgery as metabolic surgery].
TLDR
Considering the characteristic features of Japanese obese, patients who have BMI > or =35 and severe complications which need to be treated promptly should be applied to surgical treatment in Japan.
Bariatric Surgery: A Systematic Review and Meta-analysis
TLDR
Effective weight loss was achieved in morbidly obese patients after undergoing bariatric surgery, and a substantial majority of patients with diabetes, hyperlipidemia, hypertension, and obstructive sleep apnea experienced complete resolution or improvement.
Lifestyle, Diabetes, and Cardiovascular Risk Factors 10 Years after Bariatric Surgery
TLDR
A prospective, controlled Swedish Obese Subjects Study involved obese subjects who underwent gastric surgery and contemporaneously matched, conventionally treated obese control subjects, which reported follow-up data for subjects who had been enrolled for at least 2 years or 10 years before the analysis.
Effective surgical treatment of obesity may be mediated by ablation of the lipogenic gut hormone gastric inhibitory polypeptide (GIP): evidence and clinical opportunity for development of new obesity-diabetes drugs?
  • P. Flatt
  • Medicine, Biology
    Diabetes & vascular disease research
  • 2007
TLDR
Observations in animals and man suggest that GIP receptor antagonism may afford an alternative therapeutic option for treatment of obesity-diabetes, and GIP is known to play a key role in lipid metabolism and fat deposition.
Redefining Type 2 diabetes: ‘Diabesity’ or ‘Obesity Dependent Diabetes Mellitus’?
  • A. Astrup, N. Finer
  • Medicine
    Obesity reviews : an official journal of the International Association for the Study of Obesity
  • 2000
TLDR
Obesity is the main aetiogical cause of type 2 diabetes, and the term ‘diabesity’ should be adopted, and new, controlled, clinical trials show that as little as 5% weight loss is sufficient to prevent most obese subjects with impaired glucose tolerance developing type 1 diabetes.
Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution.
TLDR
Because of this body weight regulation system, known as energy homeostasis, nonsurgical methods are notoriously ineffective at achieving major, long-term weight reduction.
...
1
2
...